SELECT ISSUE

Romanian Journal of Rheumatology, Volume XXIV, No. 3, 2015
ISSN 1843-0791  |  e-ISSN 2069-6086
ISSN-L 1843-0791
DOI: 10.37897/RJR

Indexată BDI  |  IDB Indexed

DOAJ
Ebsco Host - Medline
DOI - Crossref

HIGHLIGHTS

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

PREMIU NAȚIONAL AUTORI

RJR și SRR oferă anual Premiul Național pentru Știință și Cercetare - pentru autorii celor mai bune articole științifice publicate [...]

Plagiatul – în actualitate

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]

PERIODONTAL DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: CARDIOVASCULAR RISK AND SIDE EFFECTS OF CORTICOTHERAPY INVOLVING ORAL HEALTH

, , , , , , and

ABSTRACT

Systemic lupus erythematosus (SLE) and periodontal disease (PD) are two chronic inflammatory diseases that share common pathogenetic mechanisms. Therefore, it is thought that a correlation between the two pathologies might exist. PD itself, when not associated with SLE, does not cause major cardiovascular events, but it contributes to the development of atherosclerosis, which is the major cause of death among patients with SLE. This article aims to summarize the available literature concerning the association between these two disorders (PD prevalence in patients with SLE, correlations between periodontal damage and SLEDAI activity score), to present the main mechanisms by which the two pathologies affect the cardiovascular system and to evaluate the impact of SLE corticosteroid therapy on periodontal tissue.

Keywords: systemic lupus erythematosus, periodontal disease, cardiovascular risk, corticotherapy

Full text | PDF